tiprankstipranks
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Switzerland Market
Want to see CH:BSLN full AI Analyst Report?

Basilea Pharmaceutica (BSLN) Technical Analysis

8 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
2Bullish
0Neutral
11Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Basilea Pharmaceutica’s (BSLN) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Basilea Pharmaceutica is a Buy.
Basilea Pharmaceutica’s (BSLN) 20-Day exponential moving average is 52.34, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Sell.
Basilea Pharmaceutica’s (BSLN) 50-Day exponential moving average is 52.41, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Sell.

Basilea Pharmaceutica (BSLN) Pivot Points

Aug 03, 2026, 02:40 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
Fibonacci
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Basilea Pharmaceutica (BSLN) Moving Averages

Aug 03, 2026, 02:40 AM
Period
Simple
Exponential
MA5
52.14Sell
52.12Sell
MA10
52.18Sell
52.24Sell
MA20
52.71Sell
52.34Sell
MA50
51.81Buy
52.41Sell
MA100
52.77Sell
52.52Sell
MA200
52.29Sell
51.63Buy
Basilea Pharmaceutica’s (BSLN) 10-Day exponential moving average is 52.24, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Sell.
Basilea Pharmaceutica’s (BSLN) 100-Day exponential moving average is 52.52, while Basilea Pharmaceutica’s (BSLN) share price is CHF52.6, making it a Sell.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 50-day simple moving average is 51.81, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 100-day simple moving average is 52.77, creating a Sell signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52.6 and Basilea Pharmaceutica’s (BSLN) 200-day simple moving average is 52.29, creating a Sell signal.

Basilea Pharmaceutica (BSLN) Technical Indicators

Aug 03, 2026, 02:40 AM
Name
Value
Implied Action
RSI (14)
51.29
Neutral
STOCH (9,6)
51.32
Neutral
STOCHRSI (14)
33.90
Neutral
MACD (12,26)
0.04
Buy
ADX (14)
14.88
Buy
Williams %R
-62.71
Buy
CCI (14)
-51.52
Neutral
ATR (14)
1.28
-
Ultimate Oscillator
64.38
Neutral
ROC
-2.26
Sell
Basilea Pharmaceutica’s (BSLN) Relative Strength Index (RSI) is 51.29, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Trend Strength Indicator (ADX) is 14.88, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) Commodity Channel Index (CCI) is -51.52, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Price Rate of Change (ROC) is -2.26, creating a Sell signal.

FAQ

Is BSLN a Buy, Hold, or Sell?
Based on BSLN’s technical indicators, BSLN is a Strong Sell.
    What is BSLN’s RSI (14)?
    BSLN’s RSI (14) is 51.29, which suggests BSLN is a Neutral.
      What is BSLN’s MACD?
      BSLN’s MACD is 0.04, which suggests BSLN is a Buy.
        What is BSLN’s 5-day moving average?
        BSLN’s 5-day moving average is 52.14, which suggests BSLN is a Sell.
          What is BSLN’s 20-day moving average?
          BSLN 20-day moving average is 52.71, which suggests BSLN is a Sell.
            What is BSLN’s 50-day moving average?
            BSLN’s 50-day moving average is 51.81, which suggests BSLN is a Buy.
              What is BSLN’s 200-day moving average?
              BSLN’s 200-day moving average is 52.29, which suggests BSLN is a Sell.
                What is BSLN’s Williams % R (14)?
                BSLN’s Williams % R (14) is -62.71, which suggests BSLN is a Buy.
                  What is BSLN’s CCI (14)?
                  BSLN’s CCI (14) is -51.52, which suggests BSLN is a Neutral.
                    What is the share price of Basilea Pharmaceutica?